1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Acne treatments 2012-2013 Patent Landscape

Acne treatments 2012-2013 Patent Landscape

  • July 2013
  • 70 pages
  • ID: 1557940


Table of Contents

Search Inside

This patent landscape focused on acne treatments provides statistical analysis of the new patent applications published from May 2012 to June 2013.

Acne is a common human skin disease, characterized by areas of skin with seborrhea, comedones, papules, pustules, nodules and possibly scarring. Acne affects 85 percent of adolescents, more than 10 percent of adults, and impacts people of all racial and ethnic groups. This translates to over 50 million people in the US, and over 150 million in the seven major markets. It is among the top five most economically burdensome skin diseases in the US, with total costs exceeding $3 billion per year. In spite of the large number of products in the market, acne remains the most prevalent skin disease in the world, demonstrating a high level of unmet clinical need.
The field of acne treatments has shown an intensive patenting activity since early 2000s.

Today, there are more than 11,000 patent families filed all over the world. The most active companies are L’OREAL, GALDERMA, PROCTER GAMBLE and MERCK. More than 800 new patent families were published between early May 2012 and June 2013. They were filed by over 400 patent applicants mainly located in China, Korea, USA and France. More than 1500 patent inventors are involved in acne, and about 1300 of them have filed only 1 new patent. The main patent applicants are L’ORÉAL, GALDERMA, ALLERGAN, SEA SUZHOU ELECTRONICS and ABBOTT which represent together almost 8% of the patents published from May 2012 to June 2013. Over 95% of assignees have less than 3 published patents. The academic organisms account for almost 12% of new patent filings and they are mainly located in US, China and Korea. The data set was segmented by type (Natural products and traditional medicine, Formulation, New Chemical Entity (NCE), Device, Use, Biologic, Process, Diagnostic, Combination).

Over 40% of new patent families published from May 2012 to June 2013 are related to natural products and traditional medicine. The main plant claimed in natural products is Chinese Angelica. Natural products were mainly filed by SEA SUZHOU ELECTRONICS, HANBUL COSMETICS and SEDERMA, and the patent filings remain dominated by Chinese companies. The patents claiming an invention related to Formulation and NCE represent 24% and 11% of new filings respectively. The patents dedicated to Formulation were mainly filed by ALLERGAN, GALDERMA and PROCTER & GAMBLE. The patents dedicated to NCE were mainly filed by GALDERMA, L’OREAL and the UNIVERSITY OF BRITISH COLUMBIA. Devices represent 9% of new filings and about 40% of them claimed laser or light treatments. The leading applicants are MEDICON, EMPIRE TECHNOLOGY DEVELOPMENT and ZHUOYUEJIN TECHNOLOGY. The majority of top applicants are mainly located in China and Korea.

This report also provides an Excel database of all the relevant patents KnowMade has analyzed :

Patent information
- Patent publication number
- Hyperlink to original documents
- Oldest priority date
- Title
- Abstract
- Applicants

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
TNF Inhibitors - A Pipeline Analysis Report

TNF Inhibitors - A Pipeline Analysis Report

  • $ 3500
  • Industry report
  • October 2017
  • by Infiniti Research Limited

TNF Inhibitors: An insightThe TNF inhibitors pipeline analysis report includes ongoing clinical and non-clinical trends in the global TNF inhibitors market. The anti-TNF drugs are among the top 10 global ...

Veterinary/Animal Vaccines Market by Type, Disease, Technology - Global Forecast to 2022

Veterinary/Animal Vaccines Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

“Veterinary Vaccines market is projected to register a CAGR of 5.9%”The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of ...

Antithrombin Market  - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

Antithrombin Industry: Forecasts to 2025

  • $ 5795
  • Industry report
  • October 2017
  • by Transparency Market Research

Global Antithrombin Market – OverviewThis report on antithrombin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries ...

Download Unlimited Documents from Trusted Public Sources

Pathology Statistics in the UK

  • January 2018
    9 pages
  • Pathology  

    Autoimmune Dise...  

  • United Kingdom  

View report >

Vaccine Market and Influenza Statistics in the US

  • January 2018
    9 pages
  • Vaccine  


  • United States  


View report >

Vaccine Market in the US and the Netherlands

  • January 2018
    8 pages
  • Vaccine  

  • United States  


View report >

Country Reports

United States


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.